Kizzmekia Corbett
Kizzmekia "Kizzy" Shanta Corbett (born January 26, 1986) is an American viral immunologist. She is an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and the Shutzer Assistant Professor at the Harvard Radcliffe Institute since June 2021.
Kizzmekia Corbett | |
|---|---|
| Born | Kizzmekia Shanta Corbett January 26, 1986 |
| Alma mater | University of Maryland, Baltimore County (BS) University of North Carolina, Chapel Hill (MS, PhD) |
| Known for | COVID-19 vaccine |
| Scientific career | |
| Fields | Immunology Microbiology |
| Institutions | Harvard T.H. Chan School of Public Health Harvard Radcliffe Institute National Institute of Allergy and Infectious Diseases |
| Thesis | "Characterization of Human Antibody Responses to Dengue Virus Infections in a Sri Lankan Pediatric Cohort" (2014) |
She joined Harvard following six years at the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID NIH) based in Bethesda, Maryland. She earned a PhD in microbiology and immunology from the University of North Carolina at Chapel Hill (UNC-Chapel Hill) in 2014.
Appointed to the VRC in 2014, Corbett was a postdoctoral scientist of the VRC's COVID-19 Team, with research efforts aimed at COVID-19 vaccines. In February 2021, Corbett was highlighted in the Time's "Time100 Next" list under the category of Innovators, with a profile written by Anthony Fauci.